IMMUNE NETWORK

The Korean Association of Immunobiologists (대한면역학회)
권호 표지
DOI QR코드

DOI QR Code

Role of Cordycepin and Adenosine on the Phenotypic Switch of Macrophages via Induced Anti-inflammatory Cytokines

  • Received : 2009.12.07
  • Accepted : 2009.12.16
  • Published : 2009.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Chronic low grade inflammation is closely linked to type II diabetes, obesity, and atherosclerosis. Macrophages play a key role in the regulation of pro- or anti-inflammatory actions at the lesion sites of disease. Components of cordyceps militaris, cordycepin and adenosine, have been used for the modulation of inflammatory diseases. The effects of cordycepin in the modulation of macrophages have yet to be be elucidated. We investigated the effects of cordycepin and adenosine on the morphological changes of macrophages under the inflammatory condition of LPS and an anti-inflammatory condition involving high concentrations of adenosine. Methods: We confirmed the mRNA levels of the M1/M2 cytokine genes through RT-PCR and morphological change. Results: LPS-activated macrophages returned to their inactivated original shape, i.e., they looked like naive macrophages, through the treatment with high concentrations of cordycepin ($40{\mu}g/ml$). LPS and adenosine activated macrophages also returned to their original inactivated shapes after cordycepin treatment; however, at relatively higher levels of cordycepin than adenosine. This change did not occur with relatively low concentrations of cordycepin. Adenosine down-regulated the gene expression of M1 cytokines (IL-$1{\beta}$, TNF-${\alpha}$) and chemokines (CX3CR1, RANTES), such as cordycepin. Additionally, M2 cytokines (IL-10, IL-1ra, TGF-${\beta}$) were up-regulated by both cordycepin and adenosine. Conclusion: Based on these observations, both cordycepin and adenosine regulated the phenotypic switch on macrophages and suggested that cordycepin and adenosine may potentially be used as immunomodulatory agents in the treatment of inflammatory disease.

Keywords

References

  1. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G; Atherosclerosis Risk in Communities Study: Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52;1799-1805, 2003 https://doi.org/10.2337/diabetes.52.7.1799
  2. Jacobs M, van Greevenbroek MM, van der Kallen CJ, Ferreira I, Blaak EE, Feskens EJ, Jansen EH, Schalkwijk CG, Stehouwer CD: Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study. Eur J Clin Invest 39;437-444, 2009 https://doi.org/10.1111/j.1365-2362.2009.02129.x
  3. Gregory JL, Morand EF, McKeown SJ, Ralph JA, Hall P, Yang YH, McColl SR, Hickey MJ: Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2. J Immunol 177;8072-8079, 2006 https://doi.org/10.4049/jimmunol.177.11.8072
  4. Schober A, Bernhagen J, Weber C: Chemokine-like functions of MIF in atherosclerosis. J Mol Med 86;761-770, 2008 https://doi.org/10.1007/s00109-008-0334-2
  5. Mantovani A, Sica A, Locati M: New vistas on macrophage differentiation and activation. Eur J Immunol 37;14-16, 2007 https://doi.org/10.1002/eji.200636910
  6. Meghari S, Berruyer C, Lepidi H, Galland F, Naquet P, Mege JL: Vanin-1 controls granuloma formation and macrophage polarization in Coxiella burnetii infection. Eur J Immunol 37;24-32, 2007 https://doi.org/10.1002/eji.200636054
  7. Sugar AM, McCaffrey RP: Antifungal activity of 3'-deoxyadenosine (cordycepin). Antimicrob Agents Chemother 42; 1424-1427, 1998
  8. Trigg PI, Gutteridge WE, Williamson J: The effects of cordycepin on malaria parasites. Trans R Soc Trop Med Hyg 65;514-520, 1971 https://doi.org/10.1016/0035-9203(71)90162-3
  9. de Julian-Ortiz JV, Galvez J, Munoz-Collado C, Garcia-Domenech R, Gimeno-Cardona C: Virtual combinatorial syntheses and computational screening of new potential anti-herpes compounds. J Med Chem 42;3308-3314, 1999 https://doi.org/10.1021/jm981132u
  10. Deitch AD, Sawicki SG: Effects of cordycepin on microtubules of cultured mammalian cells. Exp Cell Res 118:1-13, 1979 https://doi.org/10.1016/0014-4827(79)90577-9
  11. Yun Y, Han S, Lee S, Ko SK, Lee C, Ha NJ, Kim K: Anti-diabetic effects of CCCA, CMESS, and cordycepin from Cordyceps militaris and the immune responses in streptozotocin-induced diabetic mice. Nat Prod Sci 9;291-298, 2003
  12. Ralevic V, Burnstock G: Receptors for purines and pyrimidines. Pharmacol Rev 50;413-492, 1998
  13. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J: International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53;527-552, 2001
  14. Drury AN, Szent-Gyorgyi A: The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 68;213-237, 1929 https://doi.org/10.1113/jphysiol.1929.sp002608
  15. Mosser DM: The many faces of macrophage activation. J Leukoce Biol 73;209-212, 2003 https://doi.org/10.1189/jlb.0602325
  16. Haddad JJ, Safieh-Garabedian B, Saade NE, Kanaan SA, Land SC: Chemioxyexcitation (delta pO2/ROS)-dependent release of IL-1 beta, IL-6 and TNF-alpha: evidence of cytokines as oxygen-sensitive mediators in the alveolar epithelium. Cytokine 13;138-147, 2001 https://doi.org/10.1006/cyto.2000.0789
  17. Shin S, Lee S, Kwon J, Moon S, Lee S, Lee CK, Cho K, Ha NJ, Kim K: Cordycepin suppresses expression of diabetes regulating genes by inhibition of lipopolysaccharide-induced inflammation in macrophages. Immune Netw 9; 98-105, 2009 https://doi.org/10.4110/in.2009.9.3.98
  18. Kim HG, Shrestha B, Lim SY, Yoon DH, Chang WC, Shin DJ, Han SK, Park SM, Park JH, Park HI, Sung JM, Jang Y, Chung N, Hwang KC, Kim TW: Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-${\kappa}B$ through Akt and p38 inhibition in RAW 264.7 macrophage cells. Eur J Pharmacol 545;192-199, 2006 https://doi.org/10.1016/j.ejphar.2006.06.047

Cited by

  1. Phenotypic modulation of macrophages in response to plaque lipids vol.22, pp.5, 2009, https://doi.org/10.1097/mol.0b013e32834a97e4
  2. Protective Roles of Cordyceps on Lung Fibrosis in Cellular and Rat Models vol.143, pp.2, 2009, https://doi.org/10.1016/j.jep.2012.06.033
  3. Blockade of adipocyte differentiation by cordycepin : Anti-adipogenic effect of cordycepin vol.167, pp.3, 2009, https://doi.org/10.1111/j.1476-5381.2012.02005.x
  4. Cordycepin: pharmacological properties and their relevant mechanisms vol.2, pp.2, 2009, https://doi.org/10.5667/tang.2012.0016
  5. Immunomodulatory Activity of a Novel, Synthetic Beta-glucan (β-glu6) in Murine Macrophages and Human Peripheral Blood Mononuclear Cells vol.8, pp.11, 2009, https://doi.org/10.1371/journal.pone.0080399
  6. Effects of Cordycepin on the Microglia-Overactivation-Induced Impairments of Growth and Development of Hippocampal Cultured Neurons vol.10, pp.5, 2009, https://doi.org/10.1371/journal.pone.0125902
  7. Cordycepin protected against the TNF-α-induced inhibition of osteogenic differentiation of human adipose-derived mesenchymal stem cells vol.28, pp.3, 2009, https://doi.org/10.1177/0394632015592160
  8. Effects of Toll-like receptor ligands on RAW 264.7 macrophage morphology and zymosan phagocytosis vol.48, pp.4, 2009, https://doi.org/10.1016/j.tice.2016.04.002
  9. Cordycepin confers neuroprotection in mice models of intracerebral hemorrhage via suppressing NLRP3 inflammasome activation vol.32, pp.4, 2009, https://doi.org/10.1007/s11011-017-0003-7
  10. The Protective Effect of Cordycepin on D-Galactosamine/Lipopolysaccharide-Induced Acute Liver Injury vol.2017, pp.None, 2009, https://doi.org/10.1155/2017/3946706
  11. Pediococcus pentosaceus -Fermented Cordyceps militaris Inhibits Inflammatory Reactions and Alleviates Contact Dermatitis vol.19, pp.11, 2018, https://doi.org/10.3390/ijms19113504
  12. The polyadenylation inhibitor cordycepin reduces pain, inflammation and joint pathology in rodent models of osteoarthritis vol.9, pp.None, 2009, https://doi.org/10.1038/s41598-019-41140-1
  13. Constitutive and stimulated macropinocytosis in macrophages: roles in immunity and in the pathogenesis of atherosclerosis vol.374, pp.1765, 2019, https://doi.org/10.1098/rstb.2018.0147
  14. Fermented Cordyceps militaris Extract Ameliorates Hepatosteatosis via Activation of Fatty Acid Oxidation vol.22, pp.4, 2009, https://doi.org/10.1089/jmf.2018.4245
  15. Fermented Cordyceps militaris Extract Prevents Hepatosteatosis and Adipocyte Hypertrophy in High Fat Diet-Fed Mice vol.11, pp.5, 2009, https://doi.org/10.3390/nu11051015
  16. 건강한 성인을 대상으로 면역증강 및 상기도 감염 예방에 대한 동충하초주정추출물의 유효성 평가 : 이중맹검 플라세보 대조 연구 vol.52, pp.3, 2019, https://doi.org/10.4163/jnh.2019.52.3.258
  17. Interleukin-4 signalling pathway underlies the anxiolytic effect induced by 3-deoxyadenosine vol.236, pp.10, 2009, https://doi.org/10.1007/s00213-019-5186-7
  18. Immunomodulatory effects of a mycelium extract of Cordyceps (Paecilomyces hepiali; CBG-CS-2): a randomized and double-blind clinical trial vol.19, pp.None, 2009, https://doi.org/10.1186/s12906-019-2483-y
  19. The potential application of Cordyceps in metabolic‐related disorders vol.34, pp.2, 2009, https://doi.org/10.1002/ptr.6536
  20. A Systematic Review of the Biological Effects of Cordycepin vol.26, pp.19, 2009, https://doi.org/10.3390/molecules26195886
  21. Cordycepin Sensitizes Cholangiocarcinoma Cells to Be Killed by Natural Killer-92 (NK-92) Cells vol.26, pp.19, 2021, https://doi.org/10.3390/molecules26195973